Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sphingosine 1-phosphate signaling in perivascular cells enhances inflammation and fibrosis in the kidney
Shinji Tanaka, Shuqiu Zheng, Yugesh Kharel, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 658
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Mitochondrial oxidative damage reprograms lipid metabolism of renal tubular epithelial cells in the diabetic kidney
Yanjuan Hou, E.H. Tan, Honghong Shi, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 30
Structural and functional insights into Spns2-mediated transport of sphingosine-1-phosphate
Hongwen Chen, Shahbaz Ahmed, Hongtu Zhao, et al.
Cell (2023) Vol. 186, Iss. 12, pp. 2644-2655.e16
Open Access | Times Cited: 35
Role of perivascular cells in kidney homeostasis, inflammation, repair and fibrosis
Shinji Tanaka, Didier Portilla, Mark D. Okusa
Nature Reviews Nephrology (2023) Vol. 19, Iss. 11, pp. 721-732
Closed Access | Times Cited: 28
How do sphingosine-1-phosphate affect immune cells to resolve inflammation?
Gehui Sun, Bin Wang, Xiaoyu Wu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 13
Metabolism at the crossroads of inflammation and fibrosis in chronic kidney disease
Verónica Miguel, Isaac Shaw, Rafael Kramann
Nature Reviews Nephrology (2024)
Closed Access | Times Cited: 8
Exploring potential targets and mechanisms of renal tissue damage caused by N-(1,3-dimethylbutyl)-N′-phenyl-p-phenylenediamine quinone (6-PPDQ) through network toxicology and animal experiments: A case of chronic kidney disease
Jun Pei, Jinpu Peng, Moudong Wu, et al.
The Science of The Total Environment (2025) Vol. 964, pp. 178626-178626
Closed Access | Times Cited: 1
Single-cell RNA transcriptomic reveal the mechanism of MSC derived small extracellular vesicles against DKD fibrosis
Cheng Ji, Jiahui Zhang, Hui Shi, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Young Plasma Attenuated Chronic Kidney Disease Progression after Acute Kidney Injury by Inhibiting Inflammation in Mice
Shi-Yao Wei, Yu‐Hsiang Chou, Fan-Chi Chang, et al.
Aging and Disease (2024)
Open Access | Times Cited: 4
Bioactive sphingolipids as emerging targets for signal transduction in cancer development
Wentao Jia, Jiaying Yuan, Jinbo Zhang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189176-189176
Closed Access | Times Cited: 4
Assessment of Spinster homologue 2 (Spns2)‐dependent transport of sphingosine‐1‐phosphate as a therapeutic target
Yugesh Kharel, Tao Huang, Kyle Dunnavant, et al.
British Journal of Pharmacology (2025)
Open Access
Sphingosine kinase 1 inhibition aggravates vascular smooth muscle cell calcification
Mehdi Razazian, Sheyda Bahiraii, Isratul Jannat, et al.
Pflügers Archiv - European Journal of Physiology (2025)
Open Access
2-Aminobenzoxazole Derivatives as Potent Inhibitors of the Sphingosine-1-Phosphate Transporter Spinster Homolog 2 (Spns2)
Ariel L. Burgio, Christopher W. Shrader, Yugesh Kharel, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 8, pp. 5873-5891
Open Access | Times Cited: 10
Get me out of here: Sphingosine 1‐phosphate signaling and T cell exit from tissues during an immune response
Victoria M. Hallisey, Susan R. Schwab
Immunological Reviews (2023) Vol. 317, Iss. 1, pp. 8-19
Closed Access | Times Cited: 10
The contribution of the sphingosine 1-phosphate signaling pathway to chronic kidney diseases: recent findings and new perspectives
Stephanie Schwalm, Roxana Manaila, Anke Oftring, et al.
Pflügers Archiv - European Journal of Physiology (2024) Vol. 476, Iss. 12, pp. 1845-1861
Open Access | Times Cited: 3
Cenerimod, a sphingosine-1-phosphate receptor modulator, versus placebo in patients with moderate-to-severe systemic lupus erythematosus (CARE): an international, double-blind, randomised, placebo-controlled, phase 2 trial
Anca Askanase, David D’Cruz, Kenneth Kalunian, et al.
The Lancet Rheumatology (2024)
Closed Access | Times Cited: 3
SPHK1/S1P/S1PR pathway promotes the progression of peritoneal fibrosis by mesothelial‐mesenchymal transition
Tingting Zhao, Tao Ding, Zhengyu Sun, et al.
The FASEB Journal (2024) Vol. 38, Iss. 2
Closed Access | Times Cited: 2
1-Phosphate receptor agonists: A promising therapeutic avenue for ischemia-reperfusion injury management
Linyuan Wang, Xiaowen Zhang, Chunyan Ma, et al.
International Immunopharmacology (2024) Vol. 131, pp. 111835-111835
Closed Access | Times Cited: 2
Spinster Homologue 2 Expression Correlates With Improved Patient Survival in Hepatocellular Carcinoma Despite Association With Lymph-Angiogenesis
Joy Sarkar, Masanori Oshi, Vikas Satyananda, et al.
World Journal of Oncology (2024) Vol. 15, Iss. 2, pp. 181-191
Open Access | Times Cited: 2
The protective role of vagus nerve stimulation in ischemia-reperfusion injury
Qianqian Zhang, Lei Zhang, Guo‐Qiang Lin, et al.
Heliyon (2024) Vol. 10, Iss. 10, pp. e30952-e30952
Open Access | Times Cited: 2
Discovery of Potent, Orally Bioavailable Sphingosine-1-Phosphate Transporter (Spns2) Inhibitors
Daniel J. Foster, Kyle Dunnavant, Christopher W. Shrader, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 13, pp. 11273-11295
Open Access | Times Cited: 2
Altered sphingolipid pathway in SARS-CoV-2 infected human lung tissue
Rabisa J. Khan, Sierra L. Single, Christopher S. Simmons, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Impact of renal tubular Cpt1a overexpression on the kidney metabolome in the folic acid-induced fibrosis mouse model
Paula Cuevas-Delgado, Verónica Miguel, Francisco J. Rupérez, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 5
Microbiota-derived imidazole propionate inhibits type 2 diabetic skin wound healing by targeting SPNS2-mediated S1P transport
Shaoting Zheng, Hongqi Wang, Jingxia Han, et al.
iScience (2023) Vol. 26, Iss. 11, pp. 108092-108092
Open Access | Times Cited: 5
Assay of Sphingosine 1-phosphate Transporter Spinster Homolog 2 (Spns2) Inhibitors
Yugesh Kharel, Tao Huang, Webster L. Santos, et al.
SLAS DISCOVERY (2023) Vol. 28, Iss. 6, pp. 284-287
Open Access | Times Cited: 4
Sphingolipids and Chronic Kidney Disease
Zrinka Šakić, Armin Atić, Slavica Potočki, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 17, pp. 5050-5050
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top